J Singh - Sequent Scientific Chief Formulations
| SEQUENT Stock | 199.27 1.09 0.55% |
Executive
J Singh is Chief Formulations of Sequent Scientific Limited
| Address | Dosti Pinnacle, Mumbai, India, 400604 |
| Phone | 91 22 4111 4777 |
| Web | https://www.sequent.in |
Sequent Scientific Management Efficiency
Total Current Liabilities is likely to drop to about 3.8 B in 2024. Liabilities And Stockholders Equity is likely to drop to about 10.6 B in 2024Sequent Scientific's management efficiency ratios could be used to measure how well Sequent Scientific manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Digivijay Kapoor | Servotech Power Systems | N/A | |
| K Reddy | Mtar Technologies Limited | N/A | |
| Rasleen Kaur | PB Fintech Limited | 35 | |
| Vivek Jain | PB Fintech Limited | 35 | |
| Rupinder Kaur | Servotech Power Systems | N/A | |
| Pusparaj Sathpathy | Mtar Technologies Limited | 49 | |
| Bhasker Joshi | PB Fintech Limited | N/A | |
| Suresh Bachwani | Orient Technologies Limited | N/A | |
| Arun Handa | Servotech Power Systems | 61 | |
| Shubham Bagadia | Mtar Technologies Limited | N/A | |
| Deepti Rustagi | PB Fintech Limited | 45 | |
| Pawan Rajput | Biofil Chemicals Pharmaceutical | 34 | |
| N Mondaiah | Mtar Technologies Limited | N/A | |
| Sumit Sharma | Servotech Power Systems | N/A | |
| Devesh Dwivedi | Mtar Technologies Limited | 43 | |
| Anisha Mangal | Biofil Chemicals Pharmaceutical | 28 | |
| Swati Poddar | JGCHEMICALS LIMITED | N/A | |
| Gunneswara Pusarla | Mtar Technologies Limited | 54 | |
| Manoj Sharma | PB Fintech Limited | N/A | |
| Tata Madhusudan | Mtar Technologies Limited | 56 | |
| Anil Yadav | Servotech Power Systems | N/A | |
Management Performance
| Return On Equity | -0.0405 | ||||
| Return On Asset | 0.0031 |
Sequent Scientific Leadership Team
Elected by the shareholders, the Sequent Scientific's board of directors comprises two types of representatives: Sequent Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sequent. The board's role is to monitor Sequent Scientific's management team and ensure that shareholders' interests are well served. Sequent Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sequent Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Phillip Trott, Compliance Secretary | ||
| Prasad Lad, Vice Administration | ||
| M Shreyan, Associate Marketing | ||
| Ashish Kakabalia, VP Devel | ||
| Vedprakash Ragate, Executive Director | ||
| J Singh, Chief Formulations | ||
| Ravi Nair, Executive Administration | ||
| Saurav Bhala, Chief Officer | ||
| Ramesh Pillai, Corporate Services | ||
| Patri Rao, Chief Officer | ||
| Rajaram Narayanan, CEO MD | ||
| Abhishek Singhal, Head Relations | ||
| Sharat Narasapur, Joint Director | ||
| Krunal Shah, Company Officer |
Sequent Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sequent Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0405 | ||||
| Return On Asset | 0.0031 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 53.69 B | ||||
| Shares Outstanding | 249.35 M | ||||
| Shares Owned By Insiders | 52.98 % | ||||
| Shares Owned By Institutions | 13.16 % | ||||
| Price To Book | 7.29 X | ||||
| Price To Sales | 3.49 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sequent Stock Analysis
When running Sequent Scientific's price analysis, check to measure Sequent Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sequent Scientific is operating at the current time. Most of Sequent Scientific's value examination focuses on studying past and present price action to predict the probability of Sequent Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sequent Scientific's price. Additionally, you may evaluate how the addition of Sequent Scientific to your portfolios can decrease your overall portfolio volatility.